Saturday, October 3, 2026

Dollar Plunges to 2022 Lows as Euro Gains 14%, Triggering Global Currency Realignment

The US dollar hit its weakest level since 2022 against major currencies, with the euro surging 14% and the pound advancing 7% in 2025. Federal Reserve leadership transition uncertainty and geopolitical shifts are driving the global forex upheaval, while emerging markets face severe volatility.

ViaNews Editorial Team

February 23, 2026

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
Dollar Plunges to 2022 Lows as Euro Gains 14%, Triggering Global Currency Realignment
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

The US dollar fell to its lowest level since 2022 against major currencies, with the euro gaining 14% and the British pound advancing 7% in 2025—a currency realignment reshaping global trade and investment flows.

The pound traded at $1.3086, down 0.5% from recent highs, and fell 0.4% to €1.13—its lowest since April 2023. Jordan Rochester at Mizuho Bank projects sterling could break below $1.30 in coming months despite year-to-date gains.

Federal Reserve leadership uncertainty is weakening dollar positioning ahead of Jerome Powell's replacement in June 2026. Progress on Iran-US nuclear negotiations has added to currency volatility, while shifting central bank policies favor euro-area and UK assets over dollar holdings.

Emerging markets absorbed sharp losses. Turkey's lira plunged 17% after a carry trade collapse forced rapid unwinding of leveraged positions. Safe-haven flows pushed investors toward the Swiss franc as forex turbulence spread across developing economies.

UK gilt yields climbed to multi-decade highs, with 30-year bonds reaching 5.21%—the highest since 1998. An inflation-linked bond auction drew £69 billion in bids for £4.25 billion of debt, surpassing March's £67.5 billion record. About 25% of UK gilts are tied to inflation versus 10% in the US and France, making sterling particularly sensitive to inflation expectations.

European equity markets outperformed US indices as currency movements boosted export competitiveness. The Stoxx 600 rose 0.6% to a record 583.4 points, while France's CAC 40 gained 0.7% and Germany's DAX advanced 0.9%.

Traders are positioning for continued dollar weakness through the June 2026 Fed transition. Currency analysts are focusing on EUR/USD, GBP/USD, and emerging market pairs vulnerable to further carry trade unwinds.

Gold traded above $4,100 per ounce on dollar weakness and safe-haven demand. WTI crude rose 1.5% to around $61 per barrel as currency shifts reshaped commodity markets globally.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score3 source documents3 with a live linkVerifiability: Strong
  1. [1]News articleUk· November 12, 2025
    Pound hits two-year low against euro as Starmer under fire
  2. [2]News articleYahoo Finance· December 31, 2025
    Stock market today: Dow, S&P 500, Nasdaq post double-digit gains in 2025 as AI trade powers market once again
  3. [3]News articleYahoo Finance· February 17, 2026
    Stock market today: Dow, S&P 500, Nasdaq waver in volatile trading as AI anxiety lingers

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com